Drug Recall for Product Correction

 

HPS Pharmacies wish to advise that Pfizer Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a drug recall for product correction of:

Pfizer Lignocaine 2% Gel Syringe
Lignocaine 2%
ARTG 155647

The affected batches are shown below.

Batch

Expiry

Batch

Expiry

R91643A

31 October 2019

N96447C

31 May 2019

R91643B

31 October 2019

N96447D

31 May 2019

R91643C

31 October 2019

N96442A

30 April 2019

R91643D

31 October 2019

N96442B

30 April 2019

R87221A

31 October 2019

N96442C

30 April 2019

R87221B

31 October 2019

N96442D

30 April 2019

R87221C

31 October 2019

R87216A

31 October 2019

R87221D

31 October 2019

R87216B

31 October 2019

N96466A

31 May 2019

R87216C

31 October 2019

N96466B

31 May 2019

R87216D

31 October 2019

N96466C

31 May 2019

R49144A

31 August 2019

N96466D

31 May 2019

R49144B

31 August 2019

N96447A

31 May 2019

R49144C

31 August 2019

N96447B

31 May 2019

R49144D

31 August 2019

 

This recall for product correction has been initiated as the above batches have a low chance of containing small specks of foreign matter (~2mm) adhered to the inner surface cavity of the single-use applicator nozzle.

Please inspect your stocks by carefully rotating the syringe bag to check for visible signs of foreign matter. Closer inspection of the white nozzles is recommended once the product has been unwrapped, immediately before use. Any affected products should be quarantined for return to your supplier for a refund.

If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect your stock and quarantine all products from the batch stated above for return to the supplier for a refund. Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your clinicians if there is an immediate impact to your facility.

Product that has been inspected and found not to contain any visible foreign matter may be used and supplied as normal until the expiry date printed on the packaging.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer on (02) 9850 3333.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates